Mettler-Toledo International Inc. (MTD)
Quantitative Summary
DeterministicAt 27.7x earnings — a 57% discount to the sector average of 65.2x — MTD is in the lower valuation range. Financial health is average: Piotroski 6/9, Altman Z 9.9. DCF fair value of $169 implies 87% downside based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Mettler-Toledo International Inc. present a complex dichotomy between exceptional capital efficiency and severe accounting distortions regarding leverage. The company generates substantial value creation, evidenced by an ROIC-WACC spread of +22.2%, driven by robust profitability metrics including 59.4% gross margins and a 6/9 Piotroski F-Score alongside a high Altman Z-Score of 9.6 that signals low bankruptcy risk. However, the DuPont decomposition reveals an anomalous equity multiplier of -157.08x resulting in a negative ROE of -3677.4%, which mathematically negates the underlying operational strength despite healthy asset turnover and net margins. This structural leverage anomaly suggests the balance sheet is heavily weighted toward liabilities or specific accounting classifications rather than reflecting traditional equity risk, creating a disconnect between cash flow generation and reported return on book value.
Valuation metrics indicate significant divergence from intrinsic models relative to market pricing. While the current P/E of 29.9x trades at a discount to the sector average of 36.8x, suggesting potential undervaluation by broad comparables, the DCF fair value implies an -86.5% downside from current levels based on an assumed ten-year free cash flow growth rate of 30.5%. This stark discrepancy highlights that while revenue grows modestly at 4.0%, the market may be pricing in unrealistic long-term expansion scenarios or the model's inputs are overly aggressive given the negative equity base. The stock exhibits a clear growth tilt with a Value Factor (HML) of -0.331, yet it benefits from strong profitability factors (RMW: 0.103), positioning it as a high-quality earnings generator despite the valuation gap between DCF outputs and historical multiples.
Risk assessment data points to potential headwinds for risk-adjusted returns, specifically regarding factor exposure and insider sentiment. The annual Fama-French Alpha of -12.26% indicates underperformance relative to its factor benchmarks over time, while recent insider activity shows $1,128,096 in net selling over the last 90 days. These signals suggest that sophisticated capital may be cautious about the current price level or the sustainability of future growth assumptions required to justify the valuation multiple, even as the company maintains superior profitability characteristics within its sector.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 4% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 10.9% | 12.9% | 14.9% |
|---|---|---|---|
| 2% | $201 | $155 | $124 |
| 3% | $224 | $169 | $133 |
| 4% | $253 | $186 | $143 |
Center = base case. Green = >10% upside, Red = >10% downside vs $1170.00.
Pre-computed DCF: WACC=12.9%, terminal growth 3%. Fair value $169 (-87.4%). Not investment advice.
Valuation Context
Currently trading 49% below its 5-year average P/E of 62.0x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedMedtronic's stock is trading below both its 50-day and 200-day moving averages, indicating a technical downtrend. The Relative Strength Index (RSI) at 26.1 suggests the stock may be oversold in the short term, potentially setting up for a rebound if historical patterns hold.
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like VOT or VHT, the fund manager is mechanically forced to buy or sell MTD shares regardless of Mettler-Toledo International Inc.'s individual fundamentals. We estimate $3.7B of passive capital is structurally linked to MTD through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Mettler-Toledo International Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Mettler-Toledo International Inc. (MTD) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 1 ETFs with MTD. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 27 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
MTD Ownership Dynamics
Passive funds hold 1 in every 7 MTD shares, reducing daily market volatility.
Mettler-Toledo International Inc. (MTD) exerts notable gravity on the passive index market, currently representing 0.6% of the VOT (VOT) and 0.4% of the VHT (VHT). Across 27 tracked ETFs, approximately 3M shares (15.3% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest MTD Exposure
Float lock-up computed from 27 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
MTD Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Mettler-Toledo International Inc. over the past year sits near $1261.55 (11% of 252-day volume). The current price of $1170.00 sits 7.3% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
MTD Capital Efficiency
How efficiently does Mettler-Toledo International Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Mettler-Toledo International Inc. converts 68% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 22.2% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-08 | 78 | $1319.29 | $102,904.62 |
| 2026-05-01 | 6,477 | $1276.61 | $8.3M |
| 2026-04-14 | 107 | $1345.89 | $144,010.23 |
| 2026-04-10 | 77 | $1335.00 | $102,795 |
| 2026-04-08 | 21 | $1270.00 | $26,670 |
| 2026-04-07 | 443 | $1266.63 | $561,117.09 |
| 2026-04-06 | 1 | $1259.94 | $1,259.94 |
| 2026-03-31 | 11 | $1247.93 | $13,727.23 |
| 2026-03-30 | 7 | $1232.04 | $8,624.28 |
| 2026-03-27 | 5 | $1270.00 | $6,350 |
| 2026-03-26 | 22 | $1265.75 | $27,846.5 |
| 2026-03-25 | 2 | $1264.46 | $2,528.92 |
| 2026-03-23 | 1 | $1204.48 | $1,204.48 |
| 2026-03-16 | 2 | $1173.74 | $2,347.48 |
| 2026-03-13 | 3,549 | $1168.00 | $4.1M |
| 2026-03-05 | 8,289 | $1286.66 | $10.7M |
| 2026-03-03 | 540 | $1325.09 | $715,548.6 |
| 2026-02-20 | 342 | $1376.53 | $470,773.26 |
| 2026-02-12 | 134 | $1392.65 | $186,615.1 |
| 2026-02-11 | 205 | $1400.33 | $287,067.65 |
| 2026-02-10 | 284 | $1380.88 | $392,169.92 |
| 2026-01-22 | 148 | $1442.93 | $213,553.64 |
| 2026-01-20 | 5 | $1460.63 | $7,303.15 |
| 2025-12-19 | 386 | $1389.42 | $536,316.12 |
| 2025-12-18 | 1 | $1384.68 | $1,384.68 |
| 2025-11-20 | 10 | $1404.43 | $14,044.3 |
| 2025-11-19 | 539 | $1396.45 | $752,686.55 |
| 2025-11-10 | 1 | $1439.35 | $1,439.35 |
| 2025-10-15 | 34 | $1303.04 | $44,303.36 |
| 2025-10-08 | 22 | $1309.12 | $28,800.64 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| A | 0.828 | 0.757 | High co-movement |
| TMO | 0.768 | 0.718 | High co-movement |
| DHR | 0.765 | 0.699 | High co-movement |
| WAT | 0.678 | 0.516 | Moderate |
| SWK | 0.662 | 0.566 | Moderate |
| DOV | 0.661 | 0.632 | Moderate |
| GEHC | 0.657 | 0.606 | Moderate |
| NDSN | 0.634 | 0.583 | Moderate |
| IQV | 0.620 | 0.414 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare MTD to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.